Adamas Biotech

About:

Adamas Biotech develops nutraceutical-based prophylactic and therapeutic solutions for clinical and wellness indications.

Website: https://www.adamasbiotech.it

Top Investors: Banco BPM, Cube Labs, National Biodiversity Future Center, Istituto Nazionale Biostrutture e Biosistemi

Description:

Adamas Biotech develops clinically validated, nutraceutical-based prophylactic and therapeutic solutions for clinical and wellness indications. They offer evidence-based medicine and access to the scientific methods integral to creating innovative solutions in the nutraceutical field. Through their unique scientific-nutraceutical approach, they utilize raw materials with clinically validated biological activities. They provide antioxidant, anti-angiogenic, and anti-inflammatory properties of green tea extracts for the treatment of high-grade intraepithelial neoplasia and for blocking its progression into prostate cancer.

Total Funding Amount:

876000 EUR

Headquarters Location:

Lecce, Puglia, Italy

Founded Date:

2018-01-01

Contact Email:

info(AT)adamasbiotech.it

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-08-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai